Navigation Links
Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
Date:9/25/2007

ST. LOUIS and REHOVOT, Israel, Sept. 25 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) and Evogene Ltd. (TASE: EVGN) today announced a collaboration to improve nitrogen use efficiency in corn, soybeans, canola and cotton. Under the agreement, Monsanto gains exclusive rights to a number of genes discovered by Evogene that help plants maintain yield with lower applications of nitrogen. Monsanto will work to evaluate the use of those genes in its research and development pipeline. The potential candidates from Evogene are complementary to the nitrogen utilization genes already in testing in Monsanto's pipeline and could provide the opportunity to further a series of upgrades for this key target area. The financial terms of the agreement were not disclosed.

Nitrogen fertilizer represents one of the largest input costs in agriculture; it accounts for approximately one-fifth of the operating costs for a corn producer. In the US alone, farmers spend more than $3 billion annually on nitrogen fertilizer application of corn fields, with plants typically absorbing less than half of the nitrogen fertilizer applied.

"Improving nitrogen use efficiency in crops has immense value not only for farmers but also for our environment," said Fred Below, professor of crop physiology at the University of Illinois. "These improvements provide the greatest opportunity for increased profitability, while also offering a new way to reduce the environmental impact of corn production."

"Monsanto is continually innovating new technologies to help farmers get more out of every seed and to do more with less, including maximizing the nitrogen efficiency of crops," said Steve Padgette, Monsanto's vice president of biotechnology. "We look forward to working with Evogene to continue delivering valuable products to farmers' fields that reduce agriculture's impact on the environment."

"Monsanto is acknowledged worldwide for its excellent capabilities in delivering innovative technology to farmers," said Mr. Ofer Haviv, Evogene's President and CEO. "Therefore we are obviously delighted Monsanto has chosen our computational gene discovery technology for the development of its next generation of improved crop traits."

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information, please visit the company's web site at http://www.monsanto.com.

About Evogene (TASE: EVGN)

Evogene's mission is to be a world leader in delivering improved plant traits to the agro-biotechnology and Biofuel industries through the use of a continuously improving proprietary platform that combines state-of-the-art computational genomics, molecular biology and advanced breeding methods. Evogene's current product development portfolio includes such traits as: abiotic stress tolerance and yield, improving nitrogen use efficiency, enhancement of cotton fiber quality, increasing oil yield for the BioDiesel industry and plant manufacturing of therapeutic proteins. Evogene was founded in 2002 as a spin-off of the agro-biotechnology division of Compugen Ltd. (Nasdaq: CGEN). Evogene's core in-silico technology, the ATHLETE, is based on Compugen's proprietary LEADS computational platform. Evogene completed an IPO on the Tel Aviv Stock Exchange in June 2007.

For additional information, please visit Evogene's Website at http://www.evogene.com

This press release contains "forward-looking statements." These statements include words like "may," "expects," "believes," "scheduled" and "intends," and they describe opinions about future events. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of Evogene Ltd. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.


'/>"/>
SOURCE Monsanto Company
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GE, St. Jude to collaborate on visualization technology
2. GE Healthcare, MobileAccess to collaborate on hospital wireless
3. GE Healthcare, Harvard medical school to collaborate on nervous system research
4. Madison, Milwaukee med schools to collaborate on tech transfer
5. EraGen collaborates with Emory University on HIV detection system
6. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
7. High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors
8. High-efficiency Derivatives of the BL21 Series for Protein Expression
9. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
10. Enhancing PCR* Efficiency with MasterTaq
11. Quantification of siRNA Silencing Efficiency Using the LightCycler System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):